Scheduled to open in early 2024, Azenta Life Sciences will be locating its GENEWIZ Multiomics and Synthesis Solutions site in Oxford, UK.
Drawing upon the experienced team from the former Oxford Genomics Centre (OGC), the new Oxford Genomics Lab will provide fast and reliable genomics services from GENEWIZ to support a wide range of project needs from its customers.
Equipped with the latest next-generation sequencing (NGS) technology, the facility will be headed by Dr. David Buck, the former head of the OGC, and recognised expert in high-throughput genomics.
“We are excited to announce our new genomic services facility to the UK scientific community,” said Dr. Buck. “The OGC team members are excited to be transitioning to the new Oxford Genomics Lab, providing NGS services continuity to the Oxford scientific community.”
With full operations set from March 2024, NGS services provided by the Oxford Genomics Lab at opening will include RNA/DNA extraction, library preparation, sequencing, and bioinformatics analysis backed by experienced Ph.D.-level study managers, from project design through to delivery.
The laboratory will utilise the large network of GENEWIZ collection boxes, which offers courier pick-up to simplify the sample submission process. There will also be free-of-charge dry ice sample collection and shipping addition from the local collection boxes in Oxford and Cambridge.
GENEWIZ from Azenta is equipped with the latest, cutting-edge NGS platforms to enable service users to stay at the forefront of scientific innovation. These include Illumina NovaSeqTM X Plus, PacBio Revio, Oxford Nanopore Technologies GridION, 10x Genomics Chromium X, Nanostring GeoMx, nCounter, and Olink Protein Biomarker Detection.
For further information please visit the Oxford Genomics Lab website (https://web.genewiz.com/genewiz-oxford) or visit the Azenta stand #107, at the Festival of Genomics in London, January 24-25, 2024.
